{"created":"2023-07-25T10:22:29.646350+00:00","id":1883,"links":{},"metadata":{"_buckets":{"deposit":"2243ecd3-7315-4e61-a573-c9de3d474313"},"_deposit":{"created_by":3,"id":"1883","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"1883"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00001883","sets":["611:862:863:916"]},"author_link":["6968","6964","6972","6966","6965","6967","6969","6970","6971"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-09-28","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"26","bibliographicPageStart":"19","bibliographicVolumeNumber":"39","bibliographic_titles":[{"bibliographic_title":"秋田医学"}]}]},"item_10001_description_5":{"attribute_name":"内容記述（抄録）","attribute_value_mlt":[{"subitem_description":"We evaluated the treatment outcomes of chemoradiotherapy for patients with unresectable advanced thoracic esophageal cancer. In total, 103 patients (99 men and 4 women) with unresectable cancer (stage IVA) were treated with chemoradiotherapy between April 2003 and December 2009. They ranged in age from 48 to 89 years, with a median age of 68 years. Two courses of chemotherapy (cisplatin［CDDP］ 40 mg/m^2 on Days 1 and 8 plus 5-fluorouracil［5-FU］ 400 mg/m^2 on Days 1 through 5 and on Days 8 through 12) and radiotherapy at doses of 59.4 to 66 Gy were administered. The mean follow-up period was 15.3 months (range, 2-88 months). The median overall survival was 13.9 months. The 2-year survival rate was 33.1% and the 3-year survival rate 17.0%. Complete response (CR) was obtained in 18 patients (17.5%). Nine of the 18 patients with CR developed recurrence. Severe hematological toxicities occurred, but were tolerable.","subitem_description_type":"Other"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"秋田医学会"}]},"item_10001_source_id_11":{"attribute_name":"NCID","attribute_value_mlt":[{"subitem_source_identifier":"AN00009294","subitem_source_identifier_type":"NCID"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"03866106","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Anbai, Akira"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Koga, Makoto"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Motoyama, Satoru"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sato, Yusuke"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Jin, Mario"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Matsuhashi, Tamotsu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Shibata, Hiroyuki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Ohtsuka, Kazunori"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hashimoto, Manabu"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-02-16"}],"displaytype":"detail","filename":"aktiai39(19).pdf","filesize":[{"value":"732.6 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"aktiai39(19).pdf","url":"https://air.repo.nii.ac.jp/record/1883/files/aktiai39(19).pdf"},"version_id":"63bb0c35-a358-4ad3-898e-6fae5b4711c7"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"esophageal cancer","subitem_subject_scheme":"Other"},{"subitem_subject":"chemoradiotherapy","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER"}]},"item_type_id":"10001","owner":"3","path":["916"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-10-21"},"publish_date":"2012-10-21","publish_status":"0","recid":"1883","relation_version_is_last":true,"title":["TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER"],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-07-25T11:33:39.791607+00:00"}